Ethical Guardrails for AI in Drug Development

Russ Altman, Stanford University
and Kim Branson, GSK
In conversation with: Jack Fuchs, Stanford University

Kim Branson, senior vice president and Global Head of Artificial Intelligence and Machine Learning at GSK, examines how GSK’s AI team uses ethics-driven frameworks and checklists to consider the potential implications of new AI-driven medical innovations.